Cited by 6,670Bone Metabolism and DiseasesBone health and osteoporosis researchBone and Dental Protein Studies

The DOI matches its Crossref record; 77 of the 77 references it cites were found in a registry or an index.

Osteoclast differentiation and activation

Boyle, William J., Simonet, W. Scott, Lacey, David L.·2003·Nature

Open this paper in CoChat — free account

Abstract

Osteoclasts are specialized cells derived from the monocyte/macrophage haematopoietic lineage that develop and adhere to bone matrix, then secrete acid and lytic enzymes that degrade it in a specialized, extracellular compartment. Discovery of the RANK signalling pathway in the osteoclast has provided insight into the mechanisms of osteoclastogenesis and activation of bone resorption, and how hormonal signals impact bone structure and mass. Further study of this pathway is providing the molecular basis for developing therapeutics to treat osteoporosis and other diseases of bone loss.

Integrity signals

Registry

Crossref · 10.1038/nature01658

Cites

77 of 77 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.
Lacey, D. L., Timms, E., Tan, H.-L., Kelley, M. J., Dunstan, C. R., Burgess, T., Elliott, R., Colombero, A., Elliott, G., Scully, S., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81569-x · Cited by 5,439
Self-citation
Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.
Simonet, W. S., Lacey, D. L., Dunstan, C. R., Kelley, M., Chang, M.-S., Lüthy, R., Nguyen, H. Q., Wooden, S., Bennett, L., Boone, T., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80209-3 · Cited by 5,130
Self-citation
Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL
Yasuda, H., Shima, N., Nakagawa, N., Yamaguchi, K., Kinosaki, M., Mochizuki, S.-I., Tomoyasu, A., Yano, K., Goto, M., Murakami, A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.7.3597 · Cited by 4,224
Bone Resorption by Osteoclasts
Teitelbaum, S. L. (2000) · Science · doi:10.1126/science.289.5484.1504 · Cited by 3,962
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph node organogenesis.
Kong, Y.-Y., Yoshida, H., Sarosi, I., Tan, H.-L., Timms, E., Capparelli, C., Morony, S., Oliveira-dos-Santos, A. J., Van, G., Itie, A., et al. (1999) · Nature · doi:10.1038/16852 · Cited by 3,351
Self-citation
Induction and Activation of the Transcription Factor NFATc1 (NFAT2) Integrate RANKL Signaling in Terminal Differentiation of Osteoclasts
Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J.-I., et al. (2002) · Developmental Cell · doi:10.1016/s1534-5807(02)00369-6 · Cited by 2,701
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification.
Bucay, N., Sarosi, I., Dunstan, C. R., Morony, S., Tarpley, J., Capparelli, C., Scully, S., Tan, H. L., Xu, W., Lacey, D. L., et al. (1998) · Genes & Development · doi:10.1101/gad.12.9.1260 · Cited by 2,483
Self-citation
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z. (2002) · Nature reviews. Cancer · doi:10.1038/nrc780 · Cited by 2,476
A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function.
Anderson, D. M., Maraskovsky, E., Billingsley, W. L., Dougall, W. C., Tometsko, M. E., Roux, E. R., Teepe, M. C., DuBose, R. F., Cosman, D., & Galibert, L. (1997) · Nature · doi:10.1038/36593 · Cited by 2,290
Activated T cells regulate bone loss and joint destruction in adjuvant arthritis through osteoprotegerin ligand.
Kong, Y.-Y., Feige, U., Sarosi, I., Bolon, B., Tafuri, A., Morony, S., Capparelli, C., Li, J., Elliott, R., McCabe, S., et al. (1999) · Nature · doi:10.1038/46303 · Cited by 1,856
Self-citation

Flagged first, then by citations

Show all 77 references

Sorted by citations

Items 601–700 of 1,034

Role of oxidative stress in osteoporosis
Abdollahi, M. R., Larijani, B. A., Rahimi, R., & Salari, P. (2005) · Therapy · doi:10.2217/14750708.2.5.787 · Cited by 106
Advances in bio-nanocomposite materials for food packaging: a review
Kumar, N., Kaur, P., & Bhatia, S. (2017) · Nutrition & Food Science · doi:10.1108/nfs-11-2016-0176 · Cited by 108
The Roles of FoxO Transcription Factors in Regulation of Bone Cells Function
Ma, X., Su, P., Yin, C., Lin, X., Wang, X., Gao, Y., Patil, S., War, A. R., Qadir, A. S., Tian, Y. E., et al. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21030692 · Cited by 108
Gut microbiota modulates osteoclast glutathione synthesis and mitochondrial biogenesis in mice subjected to ovariectomy
Yin, Y., Yang, J., Zhuge, A., Li, L., & Ni, S. (2022) · Cell Proliferation · doi:10.1111/cpr.13194 · Cited by 104
The RANK/RANKL/OPG system and tumor bone metastasis: Potential mechanisms and therapeutic strategies
Zhang, Y., Liang, J., Liu, P., Wang, Q., Liu, L., & Zhao, H. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1063815 · Cited by 111
“RANKL expression by osteoblastic stromal cells is modulated by bioactive cytokines and factors that stimulate bone resorption (38).”
Background
Proteasome inhibitors abrogate osteoclast differentiation and osteoclast function
Zavrski, I., Krebbel, H., Wildemann, B., Heider, U., Kaiser, M., Possinger, K., & Sezer, O. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.05.098 · Cited by 105
Targeted expression of Cre recombinase in macrophages and osteoclasts in transgenic mice
Ferron, M., & Vacher, J. (2005) · genesis · doi:10.1002/gene.20108 · Cited by 107
“Because macrophages share a common hematopoietic precursor with the osteoclasts (Boyle et al., 2003), the cell responsible for bone matrix resorption, the osteoclast lineage was investigated ex vivo.”
Background
Wnt signaling and osteoporosis
Manolagas, S. C. (2014) · Maturitas · doi:10.1016/j.maturitas.2014.04.013 · Cited by 104
ENDOCRINOLOGY IN PREGNANCY: Bone metabolic changes during pregnancy: a period of vulnerability to osteoporosis and fracture
Sanz-Salvador, L., García‐Pérez, M. Á., Tarín, J. J., & Cano, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-14-0424 · Cited by 104
Osteocyte regulation of orthodontic force-mediated tooth movement via RANKL expression
Ayumi, S., Ono, T., Hayashi, M., Takayanagi, H., Moriyama, K., & Nakashima, T. (2017) · Scientific Reports · doi:10.1038/s41598-017-09326-7 · Cited by 106
Macrophage immunomodulation in chronic osteolytic diseases—the case of periodontitis
Sima, C., Viniegra, A., & Glogauer, M. (2018) · Journal of Leukocyte Biology · doi:10.1002/jlb.1ru0818-310r · Cited by 108
The Role Of BMPs in the Regulation of Osteoclasts Resorption and Bone Remodeling: From Experimental Models to Clinical Applications
Bordukalo-Nikšić, T., Kufner, V., & Vukičević, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869422 · Cited by 104
“During maturation, pre-osteoclasts differentiate into mononuclear cells expressing tartrate-resistant acid phosphatase (TRAP), and those TRAP-positive, mononuclear cells then fuse together into giant, multinucleated and polarized mature osteoclasts which can degrade skeletal matrix by secreting lytic enzymes (42, 43).”
Background
Palmitic Acid and DGAT1 Deficiency Enhance Osteoclastogenesis, while Oleic Acid-Induced Triglyceride Formation Prevents It
Drosatos-Tampakaki, Z., Drosatos, K., Siegelin, Y., Gong, S., Khan, S., Dyke, T. V., Goldberg, I., Schulze, P. C., & Schulze-Späte, U. (2014) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.2150 · Cited by 101
“Osteoclasts are multinucleated cells that derive from hematopoietic monocyte/macrophage precursor cells.((2)) Osteoclastogenesis mostly relies on activation of precursor cells by the receptor activator of NF‐kB ligand (RANKL).”
BackgroundMethod
Effects of zinc and strontium substitution in tricalcium phosphate on osteoclast differentiation and resorption
Roy, M., Fielding, G. A., Bandyopadhyay, A. K., & Bose, S. (2012) · Biomaterials Science · doi:10.1039/c2bm00012a · Cited by 104
Amyloid beta peptide is elevated in osteoporotic bone tissues and enhances osteoclast function
Li, S., Liu, B., Zhang, L., & Rong, L. (2014) · Bone · doi:10.1016/j.bone.2014.01.010 · Cited by 102
“Most adult skeletal diseases, such as osteoporosis, periodontitis and rheumatoid arthritis, are due to excess osteoclastic activity, leading to an imbalance in bone remodeling which favors resorption [43].”
Background
Cavin‐1/PTRF alters prostate cancer cell‐derived extracellular vesicle content and internalization to attenuate extracellular vesicle‐mediated osteoclastogenesis and osteoblast proliferation
Inder, K. L., Ruelcke, J. E., Petelin, L., Moon, H., Choi, E. A., Rae, J., Blumenthal, A., Hutmacher, D. W., Saunders, N. A., Stow, J. L., et al. (2014) · Journal of Extracellular Vesicles · doi:10.3402/jev.v3.23784 · Cited by 101
“while osteoprotegerin (OPG) acts as a RANKL decoy (35).”
Background
RANKL/RANK System-Based Mechanism for Breast Cancer Bone Metastasis and Related Therapeutic Strategies
Wu, X., Li, F., Dang, L., Liang, C., Lü, A., & Zhang, G. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00076 · Cited by 103
“The differentiation of osteoclast precursor cells also require RANKL expression from osteoclast stromal cells and RANK expression from osteoclast precursor cells (Boyle et al., 2003).”
Background
Predictive Periodontitis: The Most Promising Salivary Biomarkers for Early Diagnosis of Periodontitis
Cafiero, C., Spagnuolo, G., Marenzi, G., Martuscelli, R., Colamaio, M., & Leuci, S. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10071488 · Cited by 123
“RANKL is secreted by osteoblasts, fibroblasts, bone marrow stromal cells, and activated T and B cells [52].”
Background
Mitochondrial Sirt3 contributes to the bone loss caused by aging or estrogen deficiency
Ling, W., Krager, K. J., Richardson, K. K., Warren, A. D., Ponte, F., Aykin‐Burns, N., Manolagas, S. C., Almeida, M., & Kim, H. (2021) · JCI Insight · doi:10.1172/jci.insight.146728 · Cited by 104
“146728 NFATc1 (27), were not affected by Sirt3 deletion (Figure 4D).”
BackgroundInfluential
Synthesis and SAR of sulfonyl- and phosphoryl amidine compounds as anti-resorptive agents
Lee, M. Y., Kim, M. H., Kim, J.-H., Kim, S. H., Kim, B., Jeong, I. H., Chang, S., Kim, S. H., & Chang, S. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.11.104 · Cited by 103
The role of osteoclasts and tumour-associated macrophages in osteosarcoma metastasis
Endo‐Munoz, L., Evdokiou, A., & Saunders, N. A. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.07.003 · Cited by 108
The new concept of periodontal disease pathogenesis requires new and novel therapeutic strategies
Taubman, M. A., Kawai, T., & Han, X. (2007) · Journal Of Clinical Periodontology · doi:10.1111/j.1600-051x.2007.01065.x · Cited by 103
Translational medicine: cancer pain mechanisms and management
Delaney, A., Fleetwood-Walker, S. M., Colvin, L., & Fallon, M. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen100 · Cited by 103
FSHR gene polymorphisms influence bone mineral density and bone turnover in postmenopausal women
Rendina, D., Gianfrancesco, F., FILIPPO, G. D., Merlotti, D., Esposito, T., Mingione, A., Nuti, R., Strazzullo, P., Mossetti, G., & Gennari, L. (2010) · European Journal of Endocrinology · doi:10.1530/eje-10-0043 · Cited by 103
Thyroid hormone metabolism in skeletal development and adult bone maintenance
Waung, J. A., Bassett, J. H. D., & Williams, G. R. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.11.002 · Cited by 103
Function and regulation of microRNA‐31 in development and disease
Stepicheva, N. A., & Song, J. L. (2016) · Molecular Reproduction and Development · doi:10.1002/mrd.22678 · Cited by 104
“…reorganization in order to form a specialized extracellular compartment where protons and proteases are released to demineralize the bone (Boyle et al., 2003; Hadjidakis and Androulakis, 2006; Itzstein et al., 2011). miR-31 is highly abundant in osteoclasts, and inhibition of miR-31…”
Influential
Adrenergic control of bone remodeling and its implications for the treatment of osteoporosis.
Bonnet, N., Pierroz, D. D., & Ferrari, S. (2008) · PubMed · Cited by 101
VASCULAR CALCIFICATION IN PATIENTS WITH KIDNEY DISEASE: Inhibitors of Calcification in Blood and Urine
Schlieper, G., Westenfeld, R., Brandenburg, V. M., & Ketteler, M. (2007) · Seminars in Dialysis · doi:10.1111/j.1525-139x.2007.00257.x · Cited by 101
The Roles of Epithelial-to-Mesenchymal Transition (EMT) and Mesenchymal-to-Epithelial Transition (MET) in Breast Cancer Bone Metastasis: Potential Targets for Prevention and Treatment
Demirkan, B. (2013) · Journal of Clinical Medicine · doi:10.3390/jcm2040264 · Cited by 102
“BM microenvironment, and bone [48–53].”
Osteoclastogenesis and osteoclastic resorption of tricalcium phosphate: Effect of strontium and magnesium doping
Roy, M., & Bose, S. (2012) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.34181 · Cited by 102
“Among the cytokines, RANKL is one of the primary factors for osteoclast formation, a process known as osteoclastogenesis [7].”
Background
Epidermal growth factor receptor regulates osteoclast differentiation and survival through cross‐talking with RANK signaling
Yi, T., Lee, H., Cha, J., Ko, S., Kim, H., Shin, H., Woo, K. M., Ryoo, H., Kim, G., & Baek, J. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21511 · Cited by 103
“E-mail: baekjh@snu.ac.kr Received 24 March 2008; Accepted 9 May 2008 DOI: 10.1002/jcp.21511 Osteoclasts are multinucleated giant cells responsible for bone resorption (Boyle et al., 2003).”
BackgroundInfluential
Fibrocalcific Aortic Valve Disease
Weiss, R. M., Miller, J. D., & Heistad, D. D. (2013) · Circulation Research · doi:10.1161/circresaha.113.300153 · Cited by 105
“osteoclasts, which critically regulate tissue mineralization in bone.(92,93) It is not known, however, whether M-CSF regulates”
Background
RANKL/OPG/TRAIL plasma levels and bone mass loss evaluation in antiretroviral naive HIV‐1‐positive men
Gibellini, D., Borderi, M., Crignis, E. D., Cicola, R., Vescini, F., Caudarella, R., Chiodo, F., & Re, M. C. (2007) · Journal of Medical Virology · doi:10.1002/jmv.20938 · Cited by 102
“In particular, RANKL represents a dominant mediator of osteoclast activation/differentiation and plays a basic regulatory role in osteoblast/osteoclast cross-talk [Schoppet et al., 2002; Boyle et al., 2003].”
Corticosteroid receptors, macrophages and cardiovascular disease
Rickard, A. J., & Young, M. J. (2009) · Journal of Molecular Endocrinology · doi:10.1677/jme-08-0144 · Cited by 105
How Mouse Macrophages Sense What Is Going On
Ley, K. F., Pramod, A. B., Croft, M., Ravichandran, K. S., & Ting, J. P. ‐. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00204 · Cited by 101
“The first tissue cues were identified in osteoclasts (22) and peritoneal macrophages (23, 24).”
Background
Monocyte subsets involved in the development of systemic lupus erythematosus and rheumatoid arthritis
Hirose, S., Lin, Q., Ohtsuji, M., Nishimura, H., & Verbeek, J. S. (2019) · International Immunology · doi:10.1093/intimm/dxz036 · Cited by 106
“Intriguingly, monocytes include precursors of osteoclasts, the specialized cell type for osteoclastogenesis (10, 11).”
BackgroundInfluential
Osteoclast Signal Transduction During Bone Metastasis Formation
Győri, D., & Mócsai, A. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00507 · Cited by 107
Osteoporosis therapies and their mechanisms of action (Review)
Kim, B., Cho, Y., & Lim, W. (2021) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2021.10815 · Cited by 106
“These enzymes are released in response to PTH, and osteoclasts activated by PTH release bone minerals into the bloodstream (3,24).”
Background
Control of osteocyte dendrite formation by Sp7 and its target gene osteocrin
Wang, J. S., Kamath, T., Mazur, C. M., Mirzamohammadi, F., Rotter, D., Hojo, H., Castro, C. D., Tokavanich, N., Patel, R., Govea, N., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-26571-7 · Cited by 105
Prevention and treatment of inflammatory arthritis with traditional Chinese medicine: Underlying mechanisms based on cell and molecular targets.
Li, W.-H., Yu, L., Li, W.-M., Ge, G.-R., Ma, Y., Xiao, L., Qiao, Y.-S., Huang, W., Huang, W.-L., Wei, M.-G., et al. (2023) · Ageing Research Reviews · doi:10.1016/j.arr.2023.101981 · Cited by 98
Emdogain promotes osteoblast proliferation and differentiation and stimulates osteoprotegerin expression
He, J., Jiang, J. Q., Safavi, K. E., Spångberg, L. S. W., & Zhu, Q. (2004) · Oral Surgery Oral Medicine Oral Pathology Oral Radiology and Endodontology · doi:10.1016/j.tripleo.2003.10.005 · Cited by 101
Mechanics of molecular collagen is influenced by hydroxyapatite in natural bone
Bhowmik, R., Katti, K. S., & Katti, D. R. (2007) · Journal of Materials Science · doi:10.1007/s10853-007-1914-1 · Cited by 101
Psoriatic disease—from skin to bone
Ritchlin, C. T. (2007) · Nature Clinical Practice Rheumatology · doi:10.1038/ncprheum0670 · Cited by 102
“These precursors, derived from circulating CD14 + monocytes, differentiate into osteoclasts after exposure to monocyte colony-stimulating factor (M-CSF) and receptor activator of nuclear factor κB ligand (RANKL) expressed by synovial lining cells in inflamed psoriatic synovium”
Background
Roles for NF-κB and c-Fos in osteoclasts
Boyce, B. F., Yamashita, T., Yao, Z., Zhang, Q., Li, F., & Xing, L. (2005) · Journal of Bone and Mineral Metabolism · doi:10.1007/bf03026317 · Cited by 101
“[19]); these include NF-~cB, JNK/AP-1, NFAT2, P38, ERK, and src/AKT (Fig.”
Gain-of-function mutation in FGFR3 in mice leads to decreased bone mass by affecting both osteoblastogenesis and osteoclastogenesis.
Su, N., Sun, Q.-D., Li, C., Lu, X., Qi, H.-B., Chen, S., Yang, J., Du, X.-L., Zhao, L., He, Q., et al. (2010) · Human Molecular Genetics · doi:10.1093/hmg/ddp590 · Cited by 100
“Osteoclasts are derived from the monocyte/macrophage hematopoietic precursor cells and are unique cells responsible for bone resorption (46,47).”
Background
Oxygen-sensing PHDs regulate bone homeostasis through the modulation of osteoprotegerinPreprint
Wu, C., Rankin, E. B., Castellini, L., Fernandez-Alcudia, J., LaGory, E. L., Andersen, R., Rhodes, S. D., Wilson, T. L. S., Mohammad, K. S., Castillo, A. B., et al. (2015) · Genes & Development · doi:10.1101/gad.255000.114 · Cited by 102
“In particular, the RANK/RANKL/osteo-protegerin (OPG) axis contributes to this process by facilitating osteoblast-mediated osteoclastogenesis (Boyle et al. 2003).”
Knocking down dickkopf-1 alleviates estrogen deficiency induction of bone loss. A histomorphological study in ovariectomized rats.
Wang, F.-S., Ko, J.-Y., Lin, C.-L., Wu, H.-L., Ke, H.-J., & Tai, P.-J. (2007) · Bone · doi:10.1016/j.bone.2006.09.004 · Cited by 100
Protective effect of apigenin on Freund’s complete adjuvant-induced arthritis in rats via inhibiting P2X7/NF-κB pathway
Chang, X., He, H., Zhu, L., Gao, J., Wei, T., Zhan-qian, M., & Yan, T. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.04.021 · Cited by 100
MiR-7b directly targets DC-STAMP causing suppression of NFATc1 and c-Fos signaling during osteoclast fusion and differentiation
Dou, C., Zhang, C., Kang, F., Yang, X., Jiang, H., Bai, Y., Xiang, J., Xu, J., & Dong, S. (2014) · Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms · doi:10.1016/j.bbagrm.2014.08.002 · Cited by 100
The Role of Osteoimmunology in Periodontal Disease
Kayal, R. A. (2013) · BioMed Research International · doi:10.1155/2013/639368 · Cited by 100
“IL-17 exerts its osteoclastogenic activity by enhancing RANKL expression on osteoblasts and CD4+ T cells [42].”
Background
The role of GPCRs in bone diseases and dysfunctions
Luo, J., Sun, P., Siwko, S. K., Liu, M., & Xiao, J. (2019) · Bone Research · doi:10.1038/s41413-019-0059-6 · Cited by 102
Osteoclast fusion and bone loss are restricted by interferon inducible guanylate binding proteins
Place, D. E., Malireddi, R. K. S., Kim, J.-E., Vogel, P., Yamamoto, M., & Kanneganti, T. (2021) · Nature Communications · doi:10.1038/s41467-020-20807-8 · Cited by 104
Melatonin effects on bone: Implications for use as a therapy for managing bone loss
Munmun, F., & Witt‐Enderby, P. A. (2021) · Journal of Pineal Research · doi:10.1111/jpi.12749 · Cited by 101
Biological processes and factors involved in soft and hard tissue healing
Bartold, P. M., & Ivanovski, S. (2024) · Periodontology 2000 · doi:10.1111/prd.12546 · Cited by 111
Signaling pathways governing osteoblast proliferation, differentiation and function.
Chau, J. F. L., Leong, W. F., & Li, B. (2009) · PubMed · doi:10.14670/hh-24.1593 · Cited by 103
Regulation of osteoclast differentiation by the redox-dependent modulation of nuclear import of transcription factors
Huh, Y.-J., Kim, J.-M., Kim, H., Song, H., So, H., Lee, S. Y., Kwon, S., Kim, H. J., Kim, H., Lee, S. H., et al. (2005) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4401793 · Cited by 100
“These signaling events are intimately involved in the regulation of OC differentiation and function.(15) Once OCs have differentiated, their resorption of bone could be facilitated by ROS generated by NADPH oxidase.”
Background
Relationship Between Salivary Melatonin and Severity of Periodontal Disease
Cutando, A., Galindo‐Moreno, P., Moreno, G. G., Arana, C., Bolaños, J., Acuña-Castroviejo, D., & Wang, H. (2006) · Journal of Periodontology · doi:10.1902/jop.2006.050287 · Cited by 100
RANKL induces heterogeneous DC‐STAMP lo and DC‐STAMP hi osteoclast precursors of which the DC‐STAMP lo precursors are the master fusogens
Mensah, K. A., Ritchlin, C. T., & Schwarz, E. M. (2009) · Journal of Cellular Physiology · doi:10.1002/jcp.22012 · Cited by 100
“A pivotal event in OC development is multinucleation, which takes place when mononuclear OC precursors (OCP) fuse with one another to form polykaryons (Boyle et al., 2003).”
Background
Denosumab in patients with cancer—a surgical strike against the osteoclast
Brown, J. E., & Coleman, R. E. (2012) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2011.197 · Cited by 100
“RANKL is expressed on the surface of osteoblasts and released into the bone microenvironment, where it binds to and activates its receptor, RANK, on immature osteoclasts ( Figure 1 )”
Background
New Interleukins in Psoriasis and Psoriatic Arthritis Patients: The Possible Roles of Interleukin-33 to Interleukin-38 in Disease Activities and Bone Erosions
Li, J., Liu, L., Rui, W., Li, X., Xuan, D., Zheng, S., Yu, Y., Zhang, J., Kong, N., Zhu, X., et al. (2017) · Dermatology · doi:10.1159/000471798 · Cited by 99
An emerging role of Prevotella histicola on estrogen deficiency–induced bone loss through the gut microbiota–bone axis in postmenopausal women and in ovariectomized mice
Wang, Z., Chen, K., Wu, C., Chen, J., Pan, H., Liu, Y., Wu, P., Yuan, J., Huang, F., Lang, J., et al. (2021) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqab194 · Cited by 104
Low dose beta‐blocker prevents ovariectomy‐induced bone loss in rats without affecting heart functions
Bonnet, N., Benhamou, C. L., Malaval, L., Gonçalves, C., Vico, L., Eder, V., Pichon, C., & Courteix, D. (2008) · Journal of Cellular Physiology · doi:10.1002/jcp.21564 · Cited by 99
“JOURNAL OF CELLULAR PHYSIOLOGY Martin, 2000; Boyle et al., 2003).”
Background
Chlorogenic Acid Inhibits Osteoclast Differentiation and Bone Resorption by Down-Regulation of Receptor Activator of Nuclear Factor Kappa-B Ligand-Induced Nuclear Factor of Activated T Cells c1 Expression
Kwak, S. C., Lee, C., Kim, J., Oh, H. M., So, H., Lee, M. S., Rho, M., & Oh, J. (2013) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b13-00430 · Cited by 99
RANK, RANKL and osteoprotegerin in arthritic bone loss
Bezerra, M. C., de Carvalho, J. F., Prokopowitsch, A. S., & Pereira, R. M. R. (2005) · Brazilian Journal of Medical and Biological Research · doi:10.1590/s0100-879x2005000200004 · Cited by 99
The draft genome of blunt snout bream (Megalobrama amblycephala) reveals the development of intermuscular bone and adaptation to herbivorous diet
Liu, H., Chen, C., Gao, Z., Min, J., Gu, Y., Jiang, X., Jiang, X., Cai, H., Ebersberger, I., Xu, M., et al. (2017) · GigaScience · doi:10.1093/gigascience/gix039 · Cited by 98
“Some major developmental signals including BMP, FGF, and WNT, together with calcium/calmodulin signaling [31, 41–43], are essential for regulating the differentiation and function of osteoblasts and osteocytes and for regulating the RANKL signaling pathway for osteoclasts [44].”
Tumor metastasis to bone
Virk, M. S., & Lieberman, J. R. (2007) · Arthritis Research & Therapy · doi:10.1186/ar2169 · Cited by 101
“Stimulation of these pathways eventually results in increased formation, maturation, and survival of osteoclasts [31,32].”
Background
Real-time intravital imaging of pH variation associated with osteoclast activity
Maeda, H., Kowada, T., Kikuta, J., Furuya, M., Shirazaki, M., Mizukami, S., Ishii, M., & Kikuchi, K. (2016) · Nature Chemical Biology · doi:10.1038/nchembio.2096 · Cited by 99
Osteoclastogenesis in periodontal diseases: Possible mediators and mechanisms
AlQranei, M. S., & Chellaiah, M. A. (2020) · Journal of Oral Biosciences · doi:10.1016/j.job.2020.02.002 · Cited by 105
“RANKL promotes the fusion of the mononuclear precursors to form the multinucleated osteoclasts and hence, induce the expression of the osteoclasts-specific marker genes [24].”
Background
High dose M‐CSF partially rescues the Dap12−/− osteoclast phenotype
Faccio, R., Zou, W., Colaianni, G., Teitelbaum, S. L., & Ross, F. P. (2003) · Journal of Cellular Biochemistry · doi:10.1002/jcb.10694 · Cited by 98
“Presently, at least 24 genes or loci, the products of which positively or negatively regulate osteoclastogenesis and osteoclast function have been identified [Boyle et al., 2003; Teitelbaum and Ross, 2003].”
BackgroundInfluential
Activating transcription factor 4 regulates osteoclast differentiation in mice
Cao, H., Yu, S., Yao, Z., Galson, D. L., Jiang, Y., Zhang, X., Fan, J., Lu, B., Guan, Y., Luo, M., et al. (2010) · Journal of Clinical Investigation · doi:10.1172/jci42106 · Cited by 100
Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis
Normanno, N., Luca, A. D., Aldinucci, D., Maiello, M. R., Mancino, M., D’Antonio, A., Filippi, R. D., & Pinto, A. (2005) · Endocrine Related Cancer · doi:10.1677/erc.1.00956 · Cited by 98
“Osteoclasts represent the specialized progeny of hemopoietic precursors committed to the monocyte/macrophage lineage which, upon appropriate stimuli, fuse by giving rise to mature bone-resorbing cells (Boyle et al. 2003).”
BackgroundInfluential
The Role of Tumor Necrosis Factor Receptor Type 1 in Orthodontic Tooth Movement
Andrade, I., Silva, T. A., Silva, G. A. B., Teixeira, A. L., & Teixeira, M. M. (2007) · Journal of Dental Research · doi:10.1177/154405910708601113 · Cited by 98
“Numerous substances— such as hormones, cytokines, growth factors, and bone matrix constituents—are involved with osteoclastogenesis (Boyle et al., 2003; Kohno et al., 2003; Teitelbaum, 2007).”
Background
The effect of enoxacin on osteoclastogenesis and reduction of titanium particle-induced osteolysis via suppression of JNK signaling pathway
Liu, X., Qu, X., Wu, C., Zhai, Z., Tian, B., Li, H., Ouyang, Z., Xu, X., Wang, W., Fan, Q., et al. (2014) · Biomaterials · doi:10.1016/j.biomaterials.2014.04.006 · Cited by 97
“Previous studies revealed that NF-kB, p38, ERK1/2, and JNK play critical roles in osteoclast differentiation [13,18].”
BackgroundResult
Postmenopausal osteoporosis in rheumatoid arthritis: The estrogen deficiency-immune mechanisms link
Sapir‐Koren, R., & Livshits, G. (2017) · Bone · doi:10.1016/j.bone.2017.06.020 · Cited by 99
“RANKL may be produced either as a membrane-bound protein or it may be cleaved by metalloproteinase into a soluble molecule (sRANKL) [77].”
Background
DJ-1 controls bone homeostasis through the regulation of osteoclast differentiation
Kim, H. S., Nam, S. T., Mun, S. H., Lee, S., Kim, H., Park, Y. H., Kim, B., Won, K., Kim, H., Park, Y., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-01527-y · Cited by 98
RANKL-independent modulation of osteoclastogenesis
Feng, W., Guo, J., & Li, M. (2019) · Journal of Oral Biosciences · doi:10.1016/j.job.2019.01.001 · Cited by 99
The Role of Ca2+-NFATc1 Signaling and Its Modulation on Osteoclastogenesis
Kang, J. Y., Kang, N., Yang, Y., Hong, J. H., & Shin, D. M. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103646 · Cited by 96
“These large multinucleated cells originate from the monocyte/macrophage hematopoietic lineage [3,4].”
Background
Calcium Signaling in Osteoclast Differentiation and Bone Resorption
Kajiya, H. (2012) · Advances in experimental medicine and biology · doi:10.1007/978-94-007-2888-2_41 · Cited by 98
Microphthalmia transcription factor regulates the expression of the novel osteoclast factor GPNMB
Ripoll, V. M., Meadows, N. A., Raggatt, L. J., Chang, M. K., Pettit, A. R., Cassady, A. I., & Hume, D. A. (2008) · Gene · doi:10.1016/j.gene.2008.01.014 · Cited by 99
“Receptor activator of NF-κB ligand (RANKL) and macrophage-colony stimulating factor (CSF-1) are osteoblast products that initiate osteoclastogenesis and functional maturation of bone-resorbing activity (Kodama et al. 1991, Suda et al. 1999, Yasuda et al. 1999, Boyle et al. 2003).”
Adipokines in Psoriatic Arthritis Patients: The Correlations with Osteoclast Precursors and Bone Erosions
Xue, Y., Jiang, L., Cheng, Q., Chen, H., Yu, Y., Lin, Y., Yang, X., Kong, N., Zhu, X., Xu, X., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0046740 · Cited by 99
MicroRNA-20a regulates autophagy related protein-ATG16L1 in hypoxia-induced osteoclast differentiation
Sun, K., Chen, M. Y., Tu, M., Wang, I., Chang, S., & Li, C. (2014) · Bone · doi:10.1016/j.bone.2014.11.026 · Cited by 97
“However, when this balance shifts towards increased osteoclast activity, it ultimately results in bone loss leading to bone-related inflammatory diseases such as periodontal disease, rheumatoid arthritis and osteoporosis [2].”
Background
Experimental infection of warthos (Phacochoerus aethiopicus) with African swine fever virus.
Thomson, G. R., Gainaru, M. D., & van Dellen, A. F. (1980) · PubMed · Cited by 98
Emodin suppresses inflammatory responses and joint destruction in collagen-induced arthritic mice
Hwang, J.-K., Noh, E.-M., Moon, S.-J., Kim, J.-M., Kwon, K., Park, B.-H., You, Y., Hwang, B.-M., Kim, H.-J., Kim, B.-S., et al. (2013) · Lara D. Veeken · doi:10.1093/rheumatology/ket178 · Cited by 96
RANKL deletion in periodontal ligament and bone lining cells blocks orthodontic tooth movement
Yang, C.-Y., Jeon, H. H., Alshabab, A. Z., Lee, Y. J., Chung, C., & Graves, D. T. (2018) · International Journal of Oral Science · doi:10.1038/s41368-017-0004-8 · Cited by 96
“RANKL binds to the receptor activator of nuclear factor-κ B (RANK) and further initiates osteoclast formation and differentiation 7 .”
Background
METTL3 Modulates Osteoclast Differentiation and Function by Controlling RNA Stability and Nuclear Export
Li, D., Cai, L., Meng, R., Feng, Z., & Xu, Q. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051660 · Cited by 92
“During osteoclastogenesis, the activation of RANKL-induced MAPK, NF-κB and PI3K-AKT signaling pathways can trigger the expression of downstream transcription factors to promote mature osteoclast formation and function [20].”
BackgroundInfluential
Targeting autophagy in osteoporosis: From pathophysiology to potential therapy
Li, X., Xu, J., Dai, B., Wang, X., Guo, Q., & Qin, L. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101098 · Cited by 97
STAT3/Mitophagy Axis Coordinates Macrophage NLRP3 Inflammasome Activation and Inflammatory Bone Loss
Zhu, L., Wang, Z., Sun, X., Yu, J., Li, T., Zhao, H., Ji, Y., Peng, B., & Du, M. (2020) · Journal of Bone and Mineral Research · doi:10.1002/jbmr.4756 · Cited by 104
“Osteoclasts, the only cell type recognized competent to bone resorption, are originated from erythromyeloid progenitors and hematopoietic precursors of the monocyte-macrophage lineage.((2,3)) Inflammatory osteolysis, a devastating disease ranging from rheumatoid arthritis and periprosthetic osteolysis to apical period…”
Background
Ginsenoside-Rb2 displays anti-osteoporosis effects through reducing oxidative damage and bone-resorbing cytokines during osteogenesis
Huang, Q., Gao, B., Jie, Q., Wei, B.-Y., Fan, J., Zhang, H.-Y., Zhang, J., Li, X., Shi, J., Luo, Z., et al. (2014) · Bone · doi:10.1016/j.bone.2014.06.010 · Cited by 99
“By binding to RANK, RANKL leads to osteoclastic differentiation, prolongs osteoclastic activity and increases bone resorption [11].”
Background
Mammalian Target of Rapamycin (mTOR) Signaling Is Required for a Late-stage Fusion Process during Skeletal Myotube Maturation
Park, I., & Chen, J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506120200 · Cited by 101
Myocyte Enhancer Factor 2 and Microphthalmia-associated Transcription Factor Cooperate with NFATc1 to Transactivate the V-ATPase d2 Promoter during RANKL-induced Osteoclastogenesis
Feng, H., Cheng, T., Steer, J. H., Joyce, D. A., Pavlos, N. J., Leong, C., Kular, J., Liu, J., Feng, X., Zheng, M., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m901670200 · Cited by 97
Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement
Roato, I., Grano, M., Brunetti, G., Colucci, S. C., Mussa, A., Bertetto, O., & Ferracini, R. (2004) · The FASEB Journal · doi:10.1096/fj.04-1823fje · Cited by 95
“Osteoclastogenesis is positively or negatively regulated by a complex signaling system that involves receptor activator of nuclear factor (NF)-kB (RANK), osteoprotegerin (OPG), and receptor activator of nuclear factor (NF)-kB ligand (RANKL), all belonging to tumor necrosis factor (TNF) family (11).”
Background
The Emerging Role of YAP/TAZ in Tumor Immunity
Pan, Z., Tian, Y., Cao, C., & Niu, G. (2019) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-19-0375 · Cited by 99
“Zhao and colleagues provided novel insights into the roles of YAP in osteoclasts, which were derived from bone marrow–derived macrophages (91, 92).”
Background
Smart Nanosacrificial Layer on the Bone Surface Prevents Osteoporosis through Acid–Base Neutralization Regulated Biocascade Effects
Lin, X., Wang, Q., Gu, C., Li, M., Chen, K., Chen, P., Tang, Z., Liu, X., Pan, H., Liu, Z., et al. (2020) · Journal of the American Chemical Society · doi:10.1021/jacs.0c07309 · Cited by 95
The Role of Autophagy in Osteoclast Differentiation and Bone Resorption Function
Montaseri, A., Giampietri, C., Rossi, M., Riccioli, A., Fattore, A. D., & Filippini, A. (2020) · Biomolecules · doi:10.3390/biom10101398 · Cited by 98
“HIF-1α induces the expression of its downstream target BNIP3 (Bcl-2/adenovirus E1B 19 kDa interacting protein 3), which stimulates Beclin-1 release, increases the expression level of autophagic-related genes such as Atg5 and Atg12, recruits LC3 to autophagosome, and enhances the expression of RANKL, cathepsin K, NFATc…”
BackgroundInfluential
Extracellular acidification enhances osteoclast survival through an NFAT-independent, protein kinase C-dependent pathway
Pereverzev, A., Komarova, S. V., Korčok, J., Armstrong, S., Tremblay, G. B., Dixon, S. J., & Sims, S. M. (2007) · Bone · doi:10.1016/j.bone.2007.08.044 · Cited by 98
“A key stimulator of osteoclast formation, activity and survival is the cytokine receptor activator of NF-κB ligand (RANKL), which is antagonized by a soluble decoy receptor osteoprotegerin (OPG) [1].”
Background
Id helix-loop-helix proteins negatively regulate TRANCE-mediated osteoclast differentiation
Lee, J., Kim, K., Kim, J. H., Jin, H. M., Choi, H. K., Lee, S., Kook, H. Y., Kim, K. K., Yokota, Y., Lee, S. Y., et al. (2005) · Blood · doi:10.1182/blood-2005-07-2798 · Cited by 93
A cannabinoid 2 receptor agonist attenuates bone cancer-induced pain and bone loss
Lozano‐Ondoua, A. N., Wright, C., Vardanyan, A., King, T. E., Largent‐Milnes, T. M., Nelson, M. A., Jiménez‐Andrade, J. M., Mantyh, P. W., & Vanderah, T. W. (2010) · Life Sciences · doi:10.1016/j.lfs.2010.02.014 · Cited by 99
“Osteoclasts are cells that are derived from the monocyte-macrophage lineage (Boyle et al. 2003) and have high levels of CB2 receptors (Ofek et al. 2006, Scutt and Williamson 2007, Idris et al. 2005, and Bab and Zimmer 2008).”
Osteoporosis: integrating biomarkers and other diagnostic correlates into the management of bone fragility.
McCormick, R. K. (2007) · PubMed · Cited by 94
Recessive coding and regulatory mutations in FBLIM1 underlie the pathogenesis of chronic recurrent multifocal osteomyelitis (CRMO)
Cox, A., Darbro, B. W., Laxer, R. M., Velez, G., Bing, X., Finer, A. L., Erives, A. J., Mahajan, V. B., Bassuk, A. G., & Ferguson, P. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0169687 · Cited by 95
Lung adenocarcinoma cell-derived exosomal miR-21 facilitates osteoclastogenesis
Xu, Z., Liu, X., Wang, H., Li, J., Dai, L., Li, J., & Dong, C. (2018) · Gene · doi:10.1016/j.gene.2018.05.008 · Cited by 95

Authors: Boyle, W. J., Simonet, W. S., & Lacey, D. L.
Affiliations: Amgen (United States) (US)
Corresponding author: Boyle, William J.
ORCID: Boyle, William J.
Venue: Nature
Publisher: Springer Science and Business Media LLC
Published: 2003-05
Volume: 423
Issue: 6937
Pages: 337-342
ISSN: 0028-0836 (ISSN-L)
1476-4687
DOI: 10.1038/nature01658
OpenAlex: W2093252878
Cited by: 6,670
References: 77
Citations by year: 2026: 240 · 2025: 269 · 2024: 294 · 2023: 357 · 2022: 349 · 2021: 404 · 2020: 376 · 2019: 381 · 2018: 371 · 2017: 324 · 2016: 311 · 2015: 332 · 2014: 352 · 2013: 315 · 2012: 336
FWCI: 11.72
Type: journal article
Language: en
Open access: closed
Licence: www.springer.com/tdm (tdm)
Locations: Nature (publishedVersion)
PubMed (publishedVersion)
RePEc: Research Papers in Economics (submittedVersion)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
Health Sciences › Medicine › Orthopedics and Sports Medicine › Bone health and osteoporosis research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Bone and Dental Protein Studies
Keywords: osteoclasts, osteoclastogenesis, bone resorption, monocyte/macrophage lineage, bone matrix degradation, hormonal regulation of bone, osteoporosis
MeSH terms: Animals, Bone Resorption, Carrier Proteins, Cell Differentiation, Glycoproteins, Humans, Membrane Glycoproteins, Osteoclasts, Osteoporosis, Signal Transduction, Receptors, Tumor Necrosis Factor, Receptors, Cytoplasmic and Nuclear, Osteoprotegerin, RANK Ligand, Receptor Activator of Nuclear Factor-kappa B

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Osteoclast differentiation and activation

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks